These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 2458717)
1. High concentrations of exogenous arachidonate inhibit calcium mobilization in platelets by stimulation of adenylate cyclase. Kowalska MA; Rao AK; Disa J Biochem J; 1988 Jul; 253(1):255-62. PubMed ID: 2458717 [TBL] [Abstract][Full Text] [Related]
2. Arachidonic acid-induced calcium influx in human platelets. Comparison with the effect of thrombin. Alonso MT; Sanchez A; Garcia-Sancho J Biochem J; 1990 Dec; 272(2):435-43. PubMed ID: 2125206 [TBL] [Abstract][Full Text] [Related]
3. Response of human platelets exposed to arachidonate upon stimulation with other agonists: possible role of Ca2+i movement. Chen ZM; Cerletti C; de Gaetano G; Bertelé V Biochem Biophys Res Commun; 1987 Dec; 149(3):1193-9. PubMed ID: 3122746 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP. Haslam RJ; Davidson MM; Desjardins JV Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136 [TBL] [Abstract][Full Text] [Related]
5. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S; Westwick J; Kakkar VV Biochem Pharmacol; 1984 Oct; 33(19):3025-35. PubMed ID: 6091666 [TBL] [Abstract][Full Text] [Related]
6. Effect of phorbol 12-myristate 13-acetate (PMA) on agonist-induced arachidonate release and 5-hydroxytryptamine secretion in human platelets. Dependence of effects on agonist type and time of incubation with PMA. Krishnamurthi S; Joseph S; Kakkar VV Biochim Biophys Acta; 1987 Mar; 927(3):429-36. PubMed ID: 3101746 [TBL] [Abstract][Full Text] [Related]
7. Modulation by cyclic AMP of arachidonic acid-induced platelet desensitization. Hatmi M; Rotilio D; Haye B; Antonicelli F; Joseph D; Vargaftig BB Eur J Pharmacol; 1986 Dec; 132(2-3):219-28. PubMed ID: 3028837 [TBL] [Abstract][Full Text] [Related]
8. Platelet desensitization by arachidonic acid is associated with the suppression of endoperoxide/thromboxane A2 binding to the membrane receptor. Sato T; Hashizume T; Nakao K; Akiba S; Fujii T Biochim Biophys Acta; 1989 Aug; 992(2):168-73. PubMed ID: 2503041 [TBL] [Abstract][Full Text] [Related]
9. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor. Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526 [TBL] [Abstract][Full Text] [Related]
10. Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets. Greenberg SS; Johns A; Kleha J; Xie J; Wang Y; Bianchi J; Conley K J Pharmacol Exp Ther; 1994 Mar; 268(3):1352-61. PubMed ID: 8138950 [TBL] [Abstract][Full Text] [Related]
11. YC-1 inhibited human platelet aggregation through NO-independent activation of soluble guanylate cyclase. Wu CC; Ko FN; Kuo SC; Lee FY; Teng CM Br J Pharmacol; 1995 Oct; 116(3):1973-8. PubMed ID: 8640334 [TBL] [Abstract][Full Text] [Related]
12. Synergistic actions of paf-acether and sodium arachidonate in human platelet aggregation. 2. Unexpected results after aspirin intake. Altman R; Scazziota A Thromb Res; 1986 Jul; 43(1):113-20. PubMed ID: 3088757 [TBL] [Abstract][Full Text] [Related]
13. Synergistic potentiation of 5-hydroxytryptamine secretion by platelet agonists and phorbol myristate acetate despite inhibition of agonist-induced arachidonate/thromboxane and beta-thromboglobulin release and Ca2+ mobilization by phorbol myristate acetate. Krishnamurthi S; Joseph S; Kakkar VV Biochem J; 1986 Aug; 238(1):193-9. PubMed ID: 2948494 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin endoperoxide/thromboxane A2 receptor desensitization. Cross-talk with adenylate cyclase in human platelets. Murray R; Shipp E; FitzGerald GA J Biol Chem; 1990 Dec; 265(35):21670-5. PubMed ID: 1701435 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of aggregation and inhibition of adenylate cyclase in human platelets by prostaglandin E analogues. Matthews JS; Jones RL Br J Pharmacol; 1993 Feb; 108(2):363-9. PubMed ID: 8448586 [TBL] [Abstract][Full Text] [Related]
16. Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Jeng JH; Wu HL; Lin BR; Lan WH; Chang HH; Ho YS; Lee PH; Wang YJ; Wang JS; Chen YJ; Chang MC Atherosclerosis; 2007 Apr; 191(2):250-8. PubMed ID: 16797553 [TBL] [Abstract][Full Text] [Related]
17. Prostacyclin stimulation of the activation of blood coagulation factor X by platelets. Dutta-Roy AK; Ray TK; Sinha AK Science; 1986 Jan; 231(4736):385-8. PubMed ID: 3001935 [TBL] [Abstract][Full Text] [Related]
18. Arachidonic acid induces human platelet-fibrin retraction: the role of platelet cyclic endoperoxides. Di Minno G; Bertelé V; Cerletti C; de Gaetano G; Silver MJ Thromb Res; 1982 Feb; 25(4):299-306. PubMed ID: 6803385 [TBL] [Abstract][Full Text] [Related]
19. Involvement of cyclic AMP, iodide and metabolites of arachidonic acid in the regulation of cell proliferation of isolated porcine thyroid follicles. Gärtner R; Greil W; Demharter R; Horn K Mol Cell Endocrinol; 1985 Sep; 42(2):145-55. PubMed ID: 2998905 [TBL] [Abstract][Full Text] [Related]
20. Disparate effects of the calcium-channel blockers, nifedipine and verapamil, on alpha 2-adrenergic receptors and thromboxane A2-induced aggregation of human platelets. Johnson GJ; Leis LA; Francis GS Circulation; 1986 Apr; 73(4):847-54. PubMed ID: 3004784 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]